|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.38 USD | -5.29% |
|
-11.13% | +38.40% |
| Market Cap | 573M 504M 468M 430M 807M 55.33B 822M 5.59B 2.18B 27.11B 2.15B 2.1B 93.86B | P/E 2026 * |
-2.76x | P/E 2027 * | -3.24x |
|---|---|---|---|---|---|
| Enterprise Value | 345M 304M 282M 259M 487M 33.36B 496M 3.37B 1.31B 16.35B 1.3B 1.27B 56.6B | EV / Sales 2026 * |
29.8x | EV / Sales 2027 * | 21.1x |
| Free-Float |
96.79% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: 4D Molecular Therapeutics, Inc.
| 1 day | -5.29% | ||
| 1 week | -11.13% | ||
| Current month | -21.95% | ||
| 1 month | -0.38% | ||
| 3 months | +5.92% | ||
| 6 months | +28.31% | ||
| Current year | +38.40% |
| 1 week | 10.29 |  | 11.96 |
| 1 month | 10.29 | | 14 |
| Current year | 6.96 | | 14 |
| 1 year | 4.27 | | 14 |
| 3 years | 2.24 | | 36.25 |
| 5 years | 2.24 | | 36.25 |
| 10 years | 2.24 | | 55.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
Theresa Janke
COO | Chief Operating Officer | 51 | 2018-03-31 |
David Kirn
CEO | Chief Executive Officer | 64 | 2013-09-11 |
| Chief Tech/Sci/R&D Officer | 64 | 2024-01-01 |
| Director | Title | Age | Since |
|---|---|---|---|
David Kirn
CHM | Chairman | 64 | 2013-09-11 |
Charles Theuer
BRD | Director/Board Member | 62 | 2015-11-30 |
Jacob Chacko
BRD | Director/Board Member | 47 | 2019-02-28 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/10/26 | Sell | Founder | -15,725 | 0.0301% | ||
| 6/30/26 | Fiscal year | Compliance Officer | 19,698 | 0.0377% | ||
| 6/23/26 | Fiscal year | Compliance Officer | 29,430 | 0.0563% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.29% | -11.13% | +130.67% | -42.43% | 573M | |
| +1.08% | -6.74% | -2.31% | +10.45% | 46.06B | |
| +3.13% | +2.34% | +393.21% | +605.08% | 38.91B | |
| +2.14% | +4.98% | +10.55% | +65.45% | 35.57B | |
| +4.43% | +0.25% | +10.64% | -9.17% | 33.13B | |
| +1.23% | -1.99% | -0.05% | +30.76% | 26.42B | |
| +0.29% | -5.92% | - | - | 16.61B | |
| +14.71% | +14.47% | +26.81% | +146.99% | 15.08B | |
| -6.32% | -4.59% | +4.36% | +8.22% | 14.08B | |
| +1.82% | -1.02% | +5.46% | -30.74% | 12.81B | |
| Average | +1.39% | -2.53% | +64.37% | +87.18% | 23.92B | |
| Weighted average by Cap. | +1.90% | -2.48% | +74.25% | +129.26% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 11.6M 10.19M 9.47M 8.71M 16.34M 1.12B 16.65M 113M 44.1M 549M 43.53M 42.6M 1.9B | 17.51M 15.39M 14.3M 13.15M 24.66M 1.69B 25.13M 171M 66.56M 828M 65.7M 64.3M 2.87B |
| Net income | -277M -243M -226M -208M -390M -26.73B -397M -2.7B -1.05B -13.1B -1.04B -1.02B -45.34B | -282M -248M -230M -212M -397M -27.22B -405M -2.75B -1.07B -13.34B -1.06B -1.04B -46.18B |
| Net Debt | -227M -200M -186M -171M -320M -21.97B -326M -2.22B -865M -10.76B -854M -835M -37.27B | -203M -178M -166M -152M -286M -19.59B -291M -1.98B -771M -9.6B -761M -745M -33.24B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-23 | US$10.38 | -5.29% | 565,576 |
| 26-07-22 | US$10.96 | -3.65% | 717,183 |
| 26-07-21 | US$11.38 | +2.57% | 1,025,540 |
| 26-07-20 | US$11.09 | +0.91% | 821,598 |
| 26-07-17 | US$10.99 | +1.38% | 598,911 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FDMT Stock
Select your edition
All financial news and data tailored to specific country editions
